 | Articles: Drug/Product Approvals |
Eli Lillys Duloxetine set to become the first widely used therapeutic treatment of stress urinary incontinence
PharmiWeb, 04/08/04
First-in-class antibiotic to treat mild to moderate community-acquired respiratory tract infections
Aventis, 04/02/04
FDA Approves VIOXX® for the Acute Treatment of Migraine in Adults
Merck & Co., 04/02/04
GREES publish new recommendations on the clinical development of disease modifying osteoarthritis drugs (DMOADs)
PharmiWeb, 04/01/04
Cordis Receives FDA 510(K) Clearance Of Its Retrievable 6F OPTEASE¿ Vena Cava Filter For Patients
Johnson & Johnson, 03/31/04
Teva launches generic OxyContin
Corporate News Releases, 03/31/04
U.S. District Court Upholds DURAGESIC® Patent
Janssen Pharmaceutica, 03/30/04
Statement on Generic Oxycodone Hydrochloride Extended Release Tablets
Center for Drug Evaluation and Research, 03/29/04
SCULPTRA¿ From Dermik Laboratories Receives Recommendation For Approval With Conditions From FDA Advisory Panel
Aventis, 03/29/04
Long-term treatment with Avodart® reduces the risk of BPH progression: The patients preferred outcome
GlaxoSmithKline, 03/26/04
|
 Receive daily email updates on Drug/Product Approvals
|
|
Indexed Journals: U.S.Pharmacist, FDA Drug Alerts, Pharmiweb
more...
|
187 Available Pages
 |
|
| Read a Different Specialty |
 |
|
|
|
|
| Profession Index |
|
|
|
|
|
|
 |
| Sponsor |
|
